EBS — Emergent BioSolutions Share News
0.000.00%
Last trade - 00:00- $639.03m
- $1.08bn
- $742.90m
Brief: Emergent Biosolutions Receives $50 Million Contract Option From Barda To Procure Doses Of Cyfendus®
Russia says African, ex-Soviet countries interested in its mpox vaccine
U.S. STOCKS ON THE MOVE-BorgWarner, Digital Realty, Take-Two
U.S. STOCKS ON THE MOVE-Ralph Lauren, CoreCivic, WK Kellogg
U.S. STOCKS ON THE MOVE-Guardant Health, AppLovin, Sarepta
Emergent rises on improved 2024 sales view, narrower loss forecast
Brief: Emergent Biosolutions supports new clinical trial evaluating the safety and efficacy of Brincidofovir in treating Mpox virus across Africa
Brief: Emergent BioSolutions Q3 Revenue USD 293.8 Million
Brief: Emergent Biosolutions Appoints Dr. Simon Lowry As Chief Medical Officer And Head Of Research And Development
Brief: Emergent Biosolutions Announces The Execution Of Contract Options Valued At $67.4 Million To Procure Additional Tembexa
U.S. STOCKS ON THE MOVE-SLM Corp, Amgen Inc, Cintas Corp
U.S. STOCKS ON THE MOVE-DoorDash, KB Home, Tyson Foods
U.S. STOCKS ON THE MOVE-DoorDash, KB Home, Tyson Foods
Emergent BioSolutions rises on disclosing $400 mln in orders through 2025
Brief: Emergent Biosolutions Announces Agreement To Settle Securities Class Action Litigation
Rich nations have millions of mpox shots as Africa's outbreak spreads; Will they share? (updated)
Analysis: Rich nations have millions of mpox shots as Africa's outbreak spreads; Will they share?
Brief: Milestone Pharmaceuticals Appoints Industry Veteran Joseph Papa To Its Board
Brief: Emergent Biosolutions Successfully Refinances Debt & Further Strengthens Financial Profile